Sample results
Hepatoblastoma is a rare form of liver cancer that primarily affects infants and young children, typically under the age of three. It is caused by abnormal growth of immature liver cells (hepatocytes) and is associated with elevated levels of insulin-like growth factor 2 (IGF-2) and alpha-fetoprotein (AFP). The IGF-2 blood test is the most important test for monitoring tumor biomarkers in hepatoblastoma.
Hepatoblastoma is caused by the uncontrolled growth of immature liver cells called hepatoblasts in young children. The exact trigger for this abnormal cell growth is not fully understood, but it involves genetic mutations that disrupt normal liver cell development. Risk factors include premature birth, low birth weight, and certain genetic conditions like Beckwith-Wiedemann syndrome and familial adenomatous polyposis (FAP). The tumor cells often produce excessive amounts of insulin-like growth factor 2 (IGF-2) and alpha-fetoprotein (AFP), which serve as important biomarkers for monitoring the disease.
The IGF-2 blood test is the most important biomarker test for hepatoblastoma because it detects elevated levels of insulin-like growth factor 2, which promotes tumor cell growth and proliferation in this rare liver cancer. While the definitive diagnosis requires imaging studies (CT or MRI scans) and tissue biopsy, the IGF-2 test provides valuable information about tumor activity and can help healthcare providers monitor disease progression and treatment response. Alpha-fetoprotein (AFP) levels are also typically measured alongside IGF-2, as most children with hepatoblastoma have significantly elevated AFP levels that serve as a tumor marker throughout treatment.
You should get tested if your child shows signs such as an abdominal mass or swelling, unexplained weight loss, loss of appetite, abdominal pain, nausea and vomiting, or jaundice (yellowing of the skin and eyes). Testing is especially important for infants and toddlers under three years old who develop these symptoms, as hepatoblastoma primarily affects this age group. Children with genetic conditions like Beckwith-Wiedemann syndrome or FAP, as well as those born prematurely or with very low birth weight, should be monitored more closely as they face higher risk.
What this means
Your IGF-2 levels are slightly below the optimal range. While this alone isn't definitive, it may contribute to slower growth patterns or reduced cellular growth signals, especially when considered alongside other growth markers like IGF-1.
Recommended actions
Ensure adequate protein intake from quality sources like lean meats, fish, eggs, and dairy
Prioritize 8-10 hours of quality sleep per night, as growth factors are released during deep sleep
Work with your healthcare provider to evaluate IGF-1 and growth hormone levels for a complete assessment
Consider retesting in 3-6 months to monitor trends and treatment response
Not overhyped or overpriced. Just comprehensive blood testing made simple and for everyone.
Sample results
Your 24/7 Personal Lab Guide
Quick questions: